Leeds Children’s Hospital Appoints New Clinical Trials Coordinator

Supporting families involved in neuromuscular research

Leeds Children’s Hospital has recently appointed Mark Wareing as the new Clinical Trials Coordinator for neuromuscular research, a role funded entirely through charitable donations including support from Duchenne UK. This position aims to assist children living with rare neuromuscular conditions in accessing the latest clinical trials and research opportunities.

Role and experience of the new coordinator

Mark Wareing has been working in Leeds since 2018 and brings several years of experience in supporting families through the complexities of clinical trials. His role involves providing practical assistance to families, including help with travel and expenses, as well as offering guidance and support throughout their participation in research studies.

Objectives and responsibilities

• Ensuring every child attending Leeds Children’s Hospital has the option to participate in clinical trials if they choose
• Facilitating access to the latest neuromuscular research for patients and their families
• Providing practical support related to travel and expenses for trial participants
• Collaborating with commercial partners to secure funding for new clinical trials
• Allowing medical staff more time to focus on patient care by managing administrative aspects of trials

Mark’s appointment reflects ongoing efforts to improve research infrastructure at Leeds Children’s Hospital, with the ultimate goal of enhancing treatment options and outcomes for children affected by rare neuromuscular conditions.

Source: Leeds Hospitals Charity